Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Calgary

$90,000.00

Unravelling the complex genetic mechanisms of rare diseases using high-throughput sequencing methods

EF 2022-23

Résumé
Rare diseases (RDs) are serious, often chronic and progressive diseases. Although individually rare, considering that there are thousands of individual RDs, a large number of people are affected (~1 in 14 people). Some 80% of RDs are due to detrimental variants in the genes. In the past decade with the technological advances of high-throughput sequencing, the search for genetic causes in RDs has been successful reaching a more than 3-fold increase in the diagnostic rate (from ~12% to the current 40%-50%). However, between 50% and 60% of RD patients still remain undiagnosed even after their entire genomes are sequenced. My research aims to unravel the complex genetic mechanisms of RDs. In the Tarailo-Graovac lab, I will work with genomes of the unsolved RD patients. We focus on patients from various backgrounds who present with clearly defined clinical diagnosis, yet no or partial genetic diagnosis and children suffering from complex rare conditions highly suspected of genetic origin. In these patients, we have successfully identified complex genetic mechanisms of the known genes and developed genome sequencing (GS) pipelines to detect missed variants. This program aims to maximize the potential of cutting-edge high-throughput sequencing methods like GS, long-read sequencing, RNA sequencing to elucidate the complex genetic mechanisms of RDs. We will focus on the identification of complex genetic variants, and novel causative genes and unravelling the underlying molecular mechanisms, so as to widen the genetic spectrum, increase the diagnostic rate and provide clues for reducing the diagnostic odyssey in RDs patients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
471862
Name
Shu Li
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Unravelling the complex genetic mechanisms of rare diseases using high-throughput sequencing methods
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioinformatics Pipeline; Complex Variants; Genetic Mechanisms; Genome Sequencing; High-Throughput Sequencing; Long-Read Sequencing; Rare Diseases; Short-Read Sequencing; Structural Variants; Transcriptome
Abstract
Rare diseases (RDs) are serious, often chronic and progressive diseases. Although individually rare, considering that there are thousands of individual RDs, a large number of people are affected (~1 in 14 people). Some 80% of RDs are due to detrimental variants in the genes. In the past decade with the technological advances of high-throughput sequencing, the search for genetic causes in RDs has been successful reaching a more than 3-fold increase in the diagnostic rate (from ~12% to the current 40%-50%). However, between 50% and 60% of RD patients still remain undiagnosed even after their entire genomes are sequenced. My research aims to unravel the complex genetic mechanisms of RDs. In the Tarailo-Graovac lab, I will work with genomes of the unsolved RD patients. We focus on patients from various backgrounds who present with clearly defined clinical diagnosis, yet no or partial genetic diagnosis and children suffering from complex rare conditions highly suspected of genetic origin. In these patients, we have successfully identified complex genetic mechanisms of the known genes and developed genome sequencing (GS) pipelines to detect missed variants. This program aims to maximize the potential of cutting-edge high-throughput sequencing methods like GS, long-read sequencing, RNA sequencing to elucidate the complex genetic mechanisms of RDs. We will focus on the identification of complex genetic variants, and novel causative genes and unravelling the underlying molecular mechanisms, so as to widen the genetic spectrum, increase the diagnostic rate and provide clues for reducing the diagnostic odyssey in RDs patients.
Competitiondate
202210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Shu, Li
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~